The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin-ùThe Aprepitant Protocol 052 Study Group - Hesketh, P J; Grunberg, S M; Gralla, R J; Warr, D G; Roila, F; de Wit, R; Chawla, S P; Carides, A D; Ianus, J; Elmer, M E; Evans, J K; Beck, K; Reines, S; Horgan, K J (Journal of Clinical Oncology, 2003)